Copyright
©The Author(s) 2020.
World J Stem Cells. May 26, 2020; 12(5): 381-405
Published online May 26, 2020. doi: 10.4252/wjsc.v12.i5.381
Published online May 26, 2020. doi: 10.4252/wjsc.v12.i5.381
Ref. | Cells | Passage | Contrast agent | Concen-tration μg/mL) | Incu-bation time (h) | Strategy of interna-lization | Effici-ency | Quantification | Cellular viability | Others analysis | |||
(pgFe/cell) | Technique | Method | Results | ||||||||||
Lim et al[33] | MSC | P5-P7 | NP(BCN-Fe3O4) | 300 | 2 | Ac4ManNAz | 98.7% | 15.3 | ICP-MS | CCK-8 assay | > 95% | CF, SEM, CEM, MRI | |
Wang et al[29] | MSC | P2-P7 | Alkyl-SPIO | an appropriate amount of Alkyl-PEI/SPIO (N/P = 20) | 6 | PEI | High Eff. | NA | NA | CCK-8 assay | > 90% | BLI, MRI | |
Yun et al[30] | NSC | NR | ZnMNP | 50 | NR | PLL: 1.5 g/mL | NR | 4.6 | NR | NA | NA | TEM, BLI | |
Argibay et al[38] | MSC | P0-P2, P9, P17 | Fe3O4 | 100 | 24 | PLL: 1.5 μg/mL | High Eff. | 0.9-7.7 | ICP-OES | LDH assay | NSD | TEM | |
Duan et al[37] | MSC | P3-P5 | Fe3O4-LCP | 15 | 1.5 | PEI | Approximately 100% | Approximately 9 | AAS | CCK-8 assay | > 90% | TEM, MRI | |
Lu et al[35] | NPC | NR | C-NP | 10 | 4 | PLL and Lipofectamin | Approximately 99.3% | NA | NA | CCK-8 assay | > 95% | MRI, VFL | |
N-NP | Approximately 8.7% | ||||||||||||
Zhang et al[34] | NSC | P2-P3 | Ferritin | MOI: 10 | 24 | PLL | Approximately 63% | 3.5 | AAS | CCK-8 assay | NSD | TEM, MRI, PB | |
Lin et al[36] | MSC | P5-P9 | ASP-SPION | 30 | 1 | NA | Approximately 100% | 2.68 | AAS | CCK-8 assay | > 90% | MRI, TEM | |
Zhang et al[39] | NSC | NR | Anti-CD15-SPION | NR | NR | NA | NR | NA | NA | NA | NA | NA | |
Duan et al[40] | MSC | P3-P5 | Fe3O4-LCP | 15 | 1.5 | PEI | LCP > PLL | 8.373 | AAS | CCK-8 assay | > 90% | TEM, in vitro MRI | |
Fe3O4 | 25 | 24 | PLL | 9.214 | |||||||||
Bai et al[42] | MSC | NR | bCD-Gd | 2 μmol | 24 | PLL | NR | NA | NA | NA | NA | NA | |
Chen et al[28] | MSC | NR | GRMNB | 10 | 2 | NR | High Eff. | 33.62 | AAS | MTT | 87.6 | BLI | |
Tan et al[41] | MSC | NR | Ferucarbotran | NR | 24 | NA | Approximately 95% | NA | NA | NA | NA | NA | |
Janowski et al[44] | NSC | NR | Fe3O4 | 25 | 48 | PLL: 375 ng/mL | NR | NA | NA | NI | NI | NA | |
Park et al[43] | MSC | NR | PCION | 1 | 0.25 | PLL, EMF | NR | NA | NA | NA | NA | TEM, MRI | |
Zhang et al[45] | NPC | NA | fmNP | 5, 10, 20, 33 | 0.5, 1, 2, 3 | NA | fmNP > fdNP | 5-30 | ICP-AES | CCK-8 assay | 90%-98% | TB | |
fdNP | 1-2.5 | NA | NA | NA | |||||||||
Tarulli et al[46] | MSC | NR | MPIO | 18.8 | 24 | NA | 95% | 54 | Flow cytometry | Flow cytometry | Approximately 94% | CF | |
Liu et al[47] | NSC | NR | SPION | 14 | 24 | NA | NR | NR | NR | NI | NI | NA | |
Wang et al[48] | MSC | NR | PMNC | 0.5 mmol | 1 | NA | Approximately 100% | 16-20 | ICP-OES | CCK-8 assay | > 95% | TEM, CF, MRI | |
Lee et al[50] | MSC | P5, P6 | MGIO | 50 | 24 | NA | Approximately 97% | 33.3 | ICP-OES | NI | > 95% | TEM, microarray | |
Song et al[49] | NPC | NR | Feridex | 112.4 | 72 | NA | Approximately 100% | 0.2 | AAS | TB | Unaffected | MRI | |
Kim et al[51] | MSC | NR | Feridex | 1 | 12-16 | PS | NR | 2.6 | ICP/MS | NI | NI | NA | |
Guzman et al[52] | NSC | NR | Feridex | 5 | 24 | PS: 2.5 μg/mL | 98% | Halved every 3 d (%) | Semiquantitative (MRI) | Cell counting | Approximately 92% | NA | |
Syková et al[53] | MSC, rOEC | NR | Endorem | 112.4 | 48-72 | NA | NR | NA | NA | NA | NA | TEM | |
Zhu et al[54] | NSC | NR | Feridex | NR | 1 | Effectene | High Eff. | NA | NA | NR | NI | NA |
- Citation: Nucci MP, Filgueiras IS, Ferreira JM, de Oliveira FA, Nucci LP, Mamani JB, Rego GNA, Gamarra LF. Stem cell homing, tracking and therapeutic efficiency evaluation for stroke treatment using nanoparticles: A systematic review. World J Stem Cells 2020; 12(5): 381-405
- URL: https://www.wjgnet.com/1948-0210/full/v12/i5/381.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i5.381